Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|9|949-959

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.9, 2015-09, pp. : 949-959

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatic Arterial Infusion Chemotherapy with Epirubicin in Patients with Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 188-193

Karger

Access to resources Recommend Favorite

Evaluation of the “assessment for continuous treatment with hepatic arterial infusion chemotherapy” scoring system in patients with advanced hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E87-E97

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5‐fluorouracil

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 7, 2015-07 ,pp. : 755-763

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early response to arterial chemotherapy

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 4, 2015-04 ,pp. : 726-732

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Novel Scoring System Based on Fibrinogen and the Neutrophil-Lymphocyte Ratio as a Predictor of Chemotherapy Response and Prognosis in Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 90, Iss. 4, 2016-03 ,pp. : 186-192

Karger

Access to resources Recommend Favorite